First Midwest Bank Trust Division decreased its stake in Aetna Inc. (NYSE:AET) by 3.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 23,739 shares of the company’s stock after selling 897 shares during the period. First Midwest Bank Trust Division’s holdings in Aetna were worth $2,900,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Alps Advisors Inc. boosted its stake in shares of Aetna by 20.9% in the second quarter. Alps Advisors Inc. now owns 4,996 shares of the company’s stock valued at $610,000 after buying an additional 862 shares in the last quarter. Candriam Luxembourg S.C.A. boosted its stake in shares of Aetna by 380.9% in the second quarter. Candriam Luxembourg S.C.A. now owns 236,833 shares of the company’s stock valued at $28,926,000 after buying an additional 187,588 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Aetna by 0.3% in the second quarter. Retirement Systems of Alabama now owns 178,739 shares of the company’s stock valued at $21,829,000 after buying an additional 600 shares in the last quarter. Boston Advisors LLC acquired a new stake in shares of Aetna during the second quarter valued at about $294,000. Finally, Cullen Frost Bankers Inc. boosted its stake in shares of Aetna by 2.9% in the second quarter. Cullen Frost Bankers Inc. now owns 2,572 shares of the company’s stock valued at $314,000 after buying an additional 72 shares in the last quarter. 91.95% of the stock is currently owned by institutional investors and hedge funds.
Shares of Aetna Inc. (NYSE:AET) traded up 0.70% during midday trading on Tuesday, hitting $115.74. The company had a trading volume of 976,259 shares. The company has a market cap of $40.60 billion, a price-to-earnings ratio of 16.96 and a beta of 0.62. The stock’s 50-day moving average price is $117.27 and its 200-day moving average price is $115.69. Aetna Inc. has a 12 month low of $92.42 and a 12 month high of $123.57.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $2.21 EPS for the quarter, topping the consensus estimate of $2.12 by $0.09. The firm had revenue of $15.95 billion for the quarter, compared to analyst estimates of $15.69 billion. Aetna had a return on equity of 16.44% and a net margin of 3.89%. Aetna’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.05 EPS. On average, equities research analysts forecast that Aetna Inc. will post $8.05 EPS for the current year.
Several brokerages have recently issued reports on AET. Evercore ISI started coverage on shares of Aetna in a research report on Thursday, September 22nd. They set a “buy” rating and a $128.00 price target on the stock. Credit Suisse Group AG reaffirmed a “hold” rating and issued a $120.00 target price on shares of Aetna in a report on Tuesday, September 13th. Jefferies Group reaffirmed a “hold” rating on shares of Aetna in a report on Tuesday, September 6th. Leerink Swann reaffirmed an “outperform” rating on shares of Aetna in a report on Wednesday, August 24th. Finally, FBR & Co reaffirmed a “hold” rating on shares of Aetna in a report on Wednesday, August 17th. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Aetna currently has a consensus rating of “Buy” and an average price target of $132.79.
In other Aetna news, insider Shawn M. Guertin sold 45,328 shares of the company’s stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total value of $5,448,878.88. Following the transaction, the insider now directly owns 44,883 shares of the company’s stock, valued at approximately $5,395,385.43. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jeffrey E. Garten sold 7,100 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.